Abstract | OBJECTIVE: To explore the clinical significance of ten-eleven-translocation methylcytosine dioxygenase 2 (TET2) mRNA expression levels in adult acute myeloid leukemia patients with normal cytogenetics (CN-AML). METHODS: Expression levels of TET2 mRNA were measured by real-time PCR in 157 adult CN-AML, and its clinical impact in CN-AML was evaluated as well. RESULTS: TET2 gene expression levels from bone marrow mononuclear cells (BMMNCs) [7.29(3.41-9.99)] and CD34+ cells [6.02(5.64-6.54)] in CN-AML were significantly lower than those [BMMNCs: 8.13(6.68-9.04), P=0.026; CD34+ cells: 6.48(5.97-7.12), P=0.034] in healthy control. And TET2 mRNA level at diagnosis [7.32(6.11-8.41)] was obviously lower than that at complete remission [8.39(7.76-8.79), P<0.01]. CN-AML patients with lower levels of TET2 mRNA showed worse survival rate [(32.7±5.9)%] at 18-month than those with higher levels [(48.6±6.9)%, P=0.041]. In multivariate analysis, lower level of TET2 mRNA was an independent prognostic factor for OS [hazard ratio(HR)2.032, 95% confidence interval (CI)1.272-3.247, P=0.003] and event-free survival [HR 1.532, 95% CI 1.014-2.314, P=0.043]. CONCLUSION: The level of TET2 mRNA is significantly lower in patients with CN-AML and it is an independent negative prognostic factor. TET2 could be an important factor for the molecular-based risk stratification in CN-AML.
|
Authors | Zhijuan Zhu, Jian Chen, Mengxia Yu, Feifei Chen, Zhimei Chen, Jiyu Lou, Hongyan Tong, Jian Huang, Wenbin Qian, Haitao Meng, Jie Jin |
Journal | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
(Zhonghua Xue Ye Xue Za Zhi)
Vol. 35
Issue 9
Pg. 802-7
(Sep 2014)
ISSN: 0253-2727 [Print] China |
PMID | 25246247
(Publication Type: Journal Article)
|
Chemical References |
- DNA-Binding Proteins
- Proto-Oncogene Proteins
- Dioxygenases
- TET2 protein, human
|
Topics |
- Adult
- Cytogenetic Analysis
- Cytogenetics
- DNA-Binding Proteins
(genetics)
- Dioxygenases
- Disease-Free Survival
- Gene Expression
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Leukemia, Myeloid, Acute
(genetics)
- Proto-Oncogene Proteins
(genetics)
- Real-Time Polymerase Chain Reaction
|